Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martina Seiffert

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2020
Antibody Peptides as Cancer Vaccine-Turning Weapons to TargetsMartina Seiffert
Seminars in Hematology|June 5, 2024
Lessons learned from the Eµ-TCL1 mouse model of CLLAlessia Floerchinger, Martina Seiffert
Leukemia|May 28, 2020
T-cells in chronic lymphocytic leukemia: Guardians or drivers of disease?Philipp M Roessner, Martina Seiffert
Molecular Immunology|November 28, 2017
Beyond bystanders: Myeloid cells in chronic lymphocytic leukemiaBola S Hanna, Selcen Öztürk, Martina Seiffert
Scientific Reports|July 14, 2018
Autoantigen-Harboring Apoptotic Cells Hijack the Coinhibitory Pathway of T Cell ActivationAbraam M Yakoub, Ralph Schulz, Martina Seiffert, et al.
Cancers|April 30, 2021
IDO1-Targeted Therapy Does Not Control Disease Development in the Eµ-TCL1 Mouse Model of Chronic Lymphocytic LeukemiaSelcen Öztürk, Verena Kalter, Philipp M Roessner, et al.
Haematologica|December 8, 2010
Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2Angela Schulz, Grischa Toedt, Thorsten Zenz, et al.
Blood|July 28, 2010
Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivoMartina Seiffert, Angela Schulz, Sibylle Ohl, et al.
RNA Biology|May 16, 2013
Genome-wide identification of translationally inhibited and degraded miR-155 targets using RNA-interacting protein-IPJan Meier, Volker Hovestadt, Marc Zapatka, et al.
Leukemia & Lymphoma|October 26, 2011
Exploiting biological diversity and genomic aberrations in chronic lymphocytic leukemiaMartina Seiffert, Sascha Dietrich, Alexander Jethwa, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2020
Antibody Peptides as Cancer Vaccine-Turning Weapons to TargetsMartina Seiffert
Seminars in Hematology|June 5, 2024
Lessons learned from the Eµ-TCL1 mouse model of CLLAlessia Floerchinger, Martina Seiffert
Leukemia|May 28, 2020
T-cells in chronic lymphocytic leukemia: Guardians or drivers of disease?Philipp M Roessner, Martina Seiffert
Molecular Immunology|November 28, 2017
Beyond bystanders: Myeloid cells in chronic lymphocytic leukemiaBola S Hanna, Selcen Öztürk, Martina Seiffert
Scientific Reports|July 14, 2018
Autoantigen-Harboring Apoptotic Cells Hijack the Coinhibitory Pathway of T Cell ActivationAbraam M Yakoub, Ralph Schulz, Martina Seiffert, et al.
Cancers|April 30, 2021
IDO1-Targeted Therapy Does Not Control Disease Development in the Eµ-TCL1 Mouse Model of Chronic Lymphocytic LeukemiaSelcen Öztürk, Verena Kalter, Philipp M Roessner, et al.
Haematologica|December 8, 2010
Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2Angela Schulz, Grischa Toedt, Thorsten Zenz, et al.
Blood|July 28, 2010
Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivoMartina Seiffert, Angela Schulz, Sibylle Ohl, et al.
RNA Biology|May 16, 2013
Genome-wide identification of translationally inhibited and degraded miR-155 targets using RNA-interacting protein-IPJan Meier, Volker Hovestadt, Marc Zapatka, et al.
Leukemia & Lymphoma|October 26, 2011
Exploiting biological diversity and genomic aberrations in chronic lymphocytic leukemiaMartina Seiffert, Sascha Dietrich, Alexander Jethwa, et al.
Pageof 6